Concepedia

Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways

Cuicui Lu, Yingqi Xu, Jichao Wu, Pengzhou Hang, Yan Wang, Chen Wang, Jiancui Qi, Yong Zhang, Zhimin Du

Naunyn-Schmiedeberg s Archives of Pharmacology · 2013 · 43 citations · 29 references

DOI

Concepts

References

29

A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy

Jeffery D. Molkentin, Jianrong Lu, Christopher L. Antos et al. · Cell · 1998 · 2.6K citations · Full text

, , +14

Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy

Benjamin J. Wilkins, Yan‐Shan Dai, Orlando F. Bueno et al. · Circulation Research · 2003 · 764 citations

, , +17

Calmodulin kinase II inhibition protects against structural heart disease

Rong Zhang, Michelle S.C. Khoo, Yuejin Wu et al. · Nature Medicine · 2005 · 571 citations

, , +14

Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

Syed Haq, Gabriel Choukroun, Hae Sook Lim et al. · Circulation · 2001 · 436 citations

, , +16

The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

Johannes Backs, Thea Backs, Stefan Neef et al. · Proceedings of the National Academy of Sciences · 2009 · 433 citations · Full text

, , +17